122 related articles for article (PubMed ID: 10728625)
1. Study of borderline and invasive mucinous ovarian tumors using Ki-67 (MIB 1) antibodies and nucleolar organizer region (NOR) staining.
Terlikowski S; Sulkowski S; Lenczewski A; Musiatowicz B; Kulikowski M
Arch Gynecol Obstet; 1999 Nov; 263(1-2):29-33. PubMed ID: 10728625
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of nucleolar organizer regions in ovarian epithelial tumors.
Criscuolo M; Martinelli AM; Migaldi M; Zunarelli E; Bergamaschi M; Falchi AM; De Gaetani C
Int J Gynecol Pathol; 1993 Jul; 12(3):259-63. PubMed ID: 8344763
[TBL] [Abstract][Full Text] [Related]
3. Expression of nucleolar organizer regions (NORs) in ovarian epithelial tumors.
Terlikowski S; Lenczewski A; Famulski W; Sulkowski S; Kulikowski M
Folia Histochem Cytobiol; 2001; 39(2):161-2. PubMed ID: 11374805
[TBL] [Abstract][Full Text] [Related]
4. Mucinous tumors of the ovary: a clinicopathologic study of 196 borderline tumors (of intestinal type) and carcinomas, including an evaluation of 11 cases with 'pseudomyxoma peritonei'.
Lee KR; Scully RE
Am J Surg Pathol; 2000 Nov; 24(11):1447-64. PubMed ID: 11075847
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of proliferative activity of ovarian carcinoma as revealed by PCNA and AgNOR analyses.
Ghazizadeh M; Sasaki Y; Araki T; Konishi H; Aihara K
Am J Clin Pathol; 1997 Apr; 107(4):451-8. PubMed ID: 9124214
[TBL] [Abstract][Full Text] [Related]
6. Nuclear morphometry and AgNOR quantification: computerized image analysis on ovarian mucinous tumor imprints.
Versa-Ostojić D; Stanković T; Stemberger-Papić S; Vrdoljak-Mozetic D; Manestar M; Krasević M
Anal Quant Cytol Histol; 2008 Jun; 30(3):160-8. PubMed ID: 18630841
[TBL] [Abstract][Full Text] [Related]
7. The proliferation markers Ki-67/MIB-1, phosphohistone H3, and survivin may contribute in the identification of aggressive ovarian carcinomas.
Aune G; Stunes AK; Tingulstad S; Salvesen O; Syversen U; Torp SH
Int J Clin Exp Pathol; 2011 Jun; 4(5):444-53. PubMed ID: 21738816
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the expression of p53, MIB-1 (Ki-67 antigen), and argyrophilic nucleolar organizer regions in carcinoma of the extrahepatic bile duct.
Suto T; Sugai T; Nakamura S; Funato O; Nitta H; Sasaki R; Kanno S; Saito K
Cancer; 1998 Jan; 82(1):86-95. PubMed ID: 9428483
[TBL] [Abstract][Full Text] [Related]
9. Prognostic importance of the nucleolar organizer region score in ovarian epithelial tumors.
Zergeroğlu S; Aksakal O; Demirtürk F; Gökmen O
Gynecol Obstet Invest; 2001; 51(1):60-3. PubMed ID: 11150878
[TBL] [Abstract][Full Text] [Related]
10. Mucinous tumors of the ovary: a clinicopathologic analysis of 75 borderline tumors (of intestinal type) and carcinomas.
Rodríguez IM; Prat J
Am J Surg Pathol; 2002 Feb; 26(2):139-52. PubMed ID: 11812936
[TBL] [Abstract][Full Text] [Related]
11. Correlation of two argyrophilic nucleolar organizer region counting methods with the Ki-67 labeling index in uterine smooth muscle cell tumors.
Sawada T; Niihashi M; Oinuma T; Takekawa Y; Yoshida T; Sakurai I
Pathol Int; 1996 Feb; 46(2):142-7. PubMed ID: 10846562
[TBL] [Abstract][Full Text] [Related]
12. Mucinous tumors of the ovary: a review.
Hart WR
Int J Gynecol Pathol; 2005 Jan; 24(1):4-25. PubMed ID: 15626914
[TBL] [Abstract][Full Text] [Related]
13. P53 and Ki67 immunoexpression in mucinous malignant ovarian tumors.
Kamal CK; Simionescu CE; Mărgăritescu C; Stepan A
Rom J Morphol Embryol; 2012; 53(3 Suppl):799-803. PubMed ID: 23188443
[TBL] [Abstract][Full Text] [Related]
14. Benign, borderline, and well-differentiated malignant intestinal mucinous tumors of the ovary: a clinicopathologic, histochemical, immunohistochemical, and nuclear quantitative study of 57 cases.
de Nictolis M; Montironi R; Tommasoni S; Valli M; Pisani E; Fabris G; Prat J
Int J Gynecol Pathol; 1994 Jan; 13(1):10-21. PubMed ID: 8112952
[TBL] [Abstract][Full Text] [Related]
15. Emergence of CA125 immunoreactivity in recurrent or metastatic primary ovarian mucinous neoplasms of the intestinal type.
Miller K; Millar J; McCluggage WG
Am J Surg Pathol; 2011 Sep; 35(9):1331-6. PubMed ID: 21836488
[TBL] [Abstract][Full Text] [Related]
16. The proliferative activity of ovarian tumors of low malignant potential differs from that of ovarian carcinoma.
Nakayama K; Takebayashi Y; Hata K; Fujiwaki R; Iida K; Fukumoto M; Miyazaki K
Anticancer Res; 2003; 23(6C):4657-62. PubMed ID: 14981910
[TBL] [Abstract][Full Text] [Related]
17. Ki 67 expression in 35 borderline ovarian tumours: relations with clinicopathologic parameters and ploidy.
Darai E; Walker-Combrouze F; Dauge-Geoffroy MC; Vincent Y; Feldmann G; Madelenat P; Scoazec JY
Eur J Obstet Gynecol Reprod Biol; 1998 Feb; 76(2):175-80. PubMed ID: 9481570
[TBL] [Abstract][Full Text] [Related]
18. Stage-specific embryonic antigen 4 expression in epithelial ovarian carcinoma.
Ye F; Li Y; Hu Y; Zhou C; Hu Y; Chen H
Int J Gynecol Cancer; 2010 Aug; 20(6):958-64. PubMed ID: 20683402
[TBL] [Abstract][Full Text] [Related]
19. P53, bcl-2, ki-67 li (labeling index) status in benign, proliferative, and malignant ovarian surface epithelial neoplasms.
Gursan N; Sipal S; Calik M; Gundogdu C
Eurasian J Med; 2009 Apr; 41(1):10-4. PubMed ID: 25610057
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of tissue protein expression levels of MIB-1 (Ki-67) in Danish ovarian cancer patients. From the 'MALOVA' ovarian cancer study.
Heeran MC; Høgdall CK; Kjaer SK; Christensen L; Jensen A; Blaakaer J; Christensen IJ; Høgdall EV
APMIS; 2013 Dec; 121(12):1177-86. PubMed ID: 23594232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]